Orange Book product · Brand (NDA)
RETROVIR
ZIDOVUDINE
At a glance
Dec 19, 1995
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 19, 1995
30 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ZIDOVUDINE
Strength
200MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 020518
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2011ZIDOVUDINEBrand (NDA)
NDA 200732 · PHARMOBEDIENT
- 2009ZIDOVUDINEBrand (NDA)
NDA 022294 · AUROBINDO PHARMA
- 1990RETROVIRBrand (NDA)
NDA 019951 · VIIV HLTHCARE
- 1989RETROVIRBrand (NDA)
NDA 019910 · VIIV HLTHCARE
- 1987RETROVIRBrand (NDA)
NDA 019655 · VIIV HLTHCARE
- 2013ZIDOVUDINEGeneric (ANDA)
ANDA 204538 · LIAONING CHENGDA
- 2011ZIDOVUDINEGeneric (ANDA)
ANDA 202058 · HEC PHARM
- 2010ZIDOVUDINEGeneric (ANDA)
ANDA 090561 · CIPLA
- 2010ZIDOVUDINEGeneric (ANDA)
ANDA 091457 · AM REGENT
- 2008ZIDOVUDINEGeneric (ANDA)
ANDA 077981 · CIPLA LTD
- 2008ZIDOVUDINEGeneric (ANDA)
ANDA 090092 · HETERO LABS LTD III
- 2008ZIDOVUDINEGeneric (ANDA)
ANDA 078922 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
